DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Du Bois A, Vergote I, Ferron G. et al.
Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: the interim analysis of AGO DESKTOP III/ENGOT ov20.
J Clin Oncol 2017;
35 (15 Suppl): 5501
Access:
We do not assume any responsibility for the contents of the web pages of other providers.